MAP2K2 Antibody - C-terminal region
Catalog Number:
ASB-ARP48942_P050
- Images (4)
| Article Name: | MAP2K2 Antibody - C-terminal region |
| Biozol Catalog Number: | ASB-ARP48942_P050 |
| Supplier Catalog Number: | ARP48942_P050 |
| Alternative Catalog Number: | ASB-ARP48942_P050-25UL,ASB-ARP48942_P050-100UL |
| Manufacturer: | Aviva |
| Host: | Rabbit |
| Category: | Proteine/Peptide |
| Application: | IHC, WB |
| Species Reactivity: | Bovine, Canine, Equine, Guinea pig, Human, Mouse, Porcine, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the C terminal region of human MAP2K2 |
| Alternative Names: | CFC4, MEK2, MKK2, MAPKK2, PRKMK2 |
| MAP2K2 is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in MAP2K2 gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. |
|
|
Human Pancreas |
|
|
MAP2K2 antibody - C-terminal region (ARP48942_P050) Catalog Number: ARP48942_P050 Formalin Fixed Paraffin Embedded Tissue: Human Lung Tissue Observed Staining: Cytoplasm of pneumocytes Primary Antibody Concentration: 1:600 Secondary Antibody: Donkey anti-Rabbit-Cy3 Secondary Antibody Concentration: 1:200 Magnification: 20X Exposure Time: 0.5 - 2.0 sec |
|
|
WB Suggested Anti-MAP2K2 Antibody Titration: 0.2-1 ug/ml Positive Control: HepG2 cell lysateThere is BioGPS gene expression data showing that MAP2K2 is expressed in HepG2 |
|
|
MAP2K2 antibody - C-terminal region (ARP48942_P050) in Human HepG2 using Western Blot |
Product Guarantee and Expert Support
